| (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indole | Phase II / Phase III | rekrutiert |
| A 52-week Study of Rilzabrutinib Efficacy and Safety Compared to Placebo in Adults Diagnosed Wit | Phase III | rekrutiert |
| A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK- | Phase III | rekrutiert |
| A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorub | Phase II | rekrutiert |
| A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity | Phase III | rekrutiert |
| A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity | Phase III | rekrutiert |
| A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease | Phase III | rekrutiert |
| A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridemen | Phase III | rekrutiert |
| A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head | Phase III | rekrutiert |
| A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradi | Phase III | rekrutiert |
| A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Scle | — | rekrutiert |
| A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor f | — | rekrutiert |
| A Non-interventional, International, Multicentre Clinical Research Study to Build the Largest Co | — | rekrutiert |
| A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Even | Phase III | rekrutiert |
| A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo i | Phase III | rekrutiert |
| A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanc | Phase III | rekrutiert |
| A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, a | — | rekrutiert |
| A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severe | Phase III | rekrutiert |
| A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD | Phase III | rekrutiert |
| A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With M | Phase I / Phase II | rekrutiert |
| A Study of AZD0120 in Autoimmune Diseases | Phase I | rekrutiert |
| A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With | Phase I | rekrutiert |
| A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With | Phase I | rekrutiert |
| A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanc | Phase III | rekrutiert |
| A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early | Phase III | rekrutiert |
| A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Cro | Phase III | rekrutiert |
| A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease | Phase II / Phase III | rekrutiert |
| A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) | Phase II | rekrutiert |
| A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors | Phase I | rekrutiert |
| A Study of LY4257496 in Participants With Cancer (OMNIRAY) | Phase I | rekrutiert |
| A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembroliz | Phase III | rekrutiert |
| A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pem | Phase III | rekrutiert |
| A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With | Phase III | rekrutiert |
| A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract | Phase III | rekrutiert |
| A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemot | Phase III | rekrutiert |
| A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to S | Phase III | rekrutiert |
| A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult an | Phase III | rekrutiert |
| A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus | Phase III | rekrutiert |
| A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 | Phase III | rekrutiert |
| A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in P | Phase III | rekrutiert |
| A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Ped | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Plac | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants Wit | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Ol | Phase III | rekrutiert |
| A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Ado | Phase III | rekrutiert |
| A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus | Phase II / Phase III | rekrutiert |
| A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as | Phase II | rekrutiert |
| A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by | Phase III | rekrutiert |
| A Study to Investigate Effects of Ocrelizumab Treatment on Neurofilament Light Chain (NfL) Level | — | rekrutiert |
| A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adul | Phase III | rekrutiert |
| A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 i | Phase I | rekrutiert |
| A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Par | Phase III | rekrutiert |
| A Study to Learn About How Well BAY 3401016 Works in Adults With Alport Syndrome | Phase II | rekrutiert |
| A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in | Phase III | rekrutiert |
| A Study to Learn More About How Safe the Study Treatment Finerenone is in Long-term Use When Tak | Phase III | rekrutiert |
| A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How i | Phase III | rekrutiert |
| A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosu | Phase III | rekrutiert |
| A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of | Phase III | rekrutiert |
| A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathi | Phase III | rekrutiert |
| A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part | Phase III | rekrutiert |
| ACCESS Registry: A Post Market Follow-up Study to Monitor the Safety, Performance and Usability | — | rekrutiert |
| AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematolo | Phase I / Phase II | rekrutiert |
| Adjusted High-dose Chemotherapy With Autologous Stem Cell Transplant vs. Conventional Immunochem | Phase III | rekrutiert |
| Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leuka | Phase II / Phase III | rekrutiert |
| An Efficacy and Safety Study of Cenegermin Ophthalmic Solution Compared With Vehicle in the Trea | Phase III | rekrutiert |
| Anatomical Resection of Liver MetAstases iN patIents With RAS-mutated Colorectal Cancer | ohne Phasenangabe | rekrutiert |
| App-based Recording and Optimization of the Nutritional Status in Patients With Head and Neck Tu | ohne Phasenangabe | rekrutiert |
| Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke | Phase III | rekrutiert |
| BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatmen | — | rekrutiert |
| Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination Wit | Phase I / Phase II | rekrutiert |
| CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease | Phase I / Phase II | rekrutiert |
| CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer. | Phase II | rekrutiert |
| CATCH: Implementation of Genomics-guided Precision Medicine in Metastatic Breast Cancer | — | rekrutiert |
| COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer | — | rekrutiert |
| Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello- | Phase III | rekrutiert |
| Characterization of Renal Microvascular Alterations in Patients With Active Urinary Sediment and | — | rekrutiert |
| Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) | — | rekrutiert |
| Clinical Benefit and Biomarker Analysis of Combination of PD-1/PD-L1 Immune Checkpoint Inhibitor | — | rekrutiert |
| Colorectal Resections in Patients With Retroperitoneal Sarcoma | — | rekrutiert |
| Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Loca | Phase IV | rekrutiert |
| Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lym | Phase II | rekrutiert |
| Comparison of LAA-Closure vs Oral Anticoagulation in Patients With NVAF and Status Post Intracra | ohne Phasenangabe | rekrutiert |
| Comparison of Optical Coherence Tomography-derived Minimal Lumen Area, Invasive Fractional Flow | ohne Phasenangabe | rekrutiert |
| Comparison of Vessel-FFR Versus FFR in Intermediate Coronary Stenoses | ohne Phasenangabe | rekrutiert |
| Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women | ohne Phasenangabe | rekrutiert |
| Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI | ohne Phasenangabe | rekrutiert |
| Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Re | Phase IV | rekrutiert |
| DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to C | Phase III | rekrutiert |
| DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung | Phase II | rekrutiert |
| DEfeating PEnile CAncer-2 | ohne Phasenangabe | rekrutiert |
| Dapagliflozin on Renal Morphology and Renal Perfusion in Patients One Year After Kidney Transpla | Phase IV | rekrutiert |
| De-Intensification of Postoperative Radiotherapy in Patients With Squamous Cell Carcinoma of the | Phase II / Phase III | rekrutiert |
| Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Saf | Phase III | rekrutiert |
| Durvalumab With Consolidative Radiochemotherapy and Ablative Stereotactic Radiotherapy in Oligom | Phase II | rekrutiert |
| EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1) | Phase I / Phase II | rekrutiert |
| Effect of Renal Denervation on Bood Pressure in Patients on Hemodialysis | ohne Phasenangabe | rekrutiert |
| Effects of Dietary Supplementation With omega3-fatty Acids (Fish Oil) and Progressive Resistance | ohne Phasenangabe | rekrutiert |
| Effects of Intermittent Fasting and Exercise on Inflammation, Metabolism, and the Microbiome in | ohne Phasenangabe | rekrutiert |
| Efficacy and Safety of MB-CART2019.1 vs. SoC in Lymphoma Patients | Phase II | rekrutiert |
| Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease | Phase II | rekrutiert |
| Efficacy of Add-on Plasma Exchange As an Adjunctive Strategy Against Septic Shock | ohne Phasenangabe | rekrutiert |
| Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do N | Phase II | rekrutiert |
| Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failur | Phase II / Phase III | rekrutiert |
| Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort | — | rekrutiert |
| Establishment and Evaluation of Standardized Clinical, Biological and Imaging Parameters to Asse | — | rekrutiert |
| Evaluating the Effectiveness of Typology-based Coaching on Patients' Therapy Management | ohne Phasenangabe | rekrutiert |
| Evaluation Of Outcomes Following Rotator Cuff Repair Using the REGENETEN Bioinductive Implant | — | rekrutiert |
| Evaluation of Acute and Chronic Nephrotoxicity in Acute Lymphatic Leukemia Patients Using Ultras | ohne Phasenangabe | rekrutiert |
| Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell | Phase II | rekrutiert |
| Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate R | Phase III | rekrutiert |
| Exploratory Investigation of the Acceptance and Utility of 14-day Trial Periods and Application- | ohne Phasenangabe | rekrutiert |
| Filter Lifespan in Continuous Renal Replacement Therapy | — | rekrutiert |
| First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antine | Phase I / Phase II | rekrutiert |
| Fistula-in-ano in Infants and Children | ohne Phasenangabe | rekrutiert |
| Flexi Band Resistance Training Versus EMS Exercise in Patients With the Diagnosis of Malignant D | ohne Phasenangabe | rekrutiert |
| Focal Brachytherapy in Patients With Selected "Low-risk" Prostate Cancer - a Phase-II-trial | Phase II | rekrutiert |
| Fontan-Sprechstunde | ohne Phasenangabe | rekrutiert |
| GISAR German Interdisciplinary Sarcoma Registry | — | rekrutiert |
| GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, T | — | rekrutiert |
| GMMG Multiple Myeloma Registry | — | rekrutiert |
| Genomics Guided Targeted Post-neoadjuvant Therapy in Patients With Early Breast Cancer (COGNITIO | Phase II | rekrutiert |
| German Dementia Registry | — | rekrutiert |
| Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children a | — | rekrutiert |
| HDClarity: a Multi-site Cerebrospinal Fluid Collection Initiative to Facilitate Therapeutic Deve | — | rekrutiert |
| IMA402 T Cell-Engaging Receptor Molecule (TCER®) in Recurrent and/or Refractory Solid Tumors | Phase I / Phase II | rekrutiert |
| IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL | Phase III | rekrutiert |
| ITP Registry and Accompanying Biospecimen Collection | — | rekrutiert |
| Immune Biomarker Study for Cisplatin-ineligible Patients Receiving Chemoradiotherapy With Doceta | — | rekrutiert |
| Immune Biomarker Study for Head and Neck Cancer | — | rekrutiert |
| Immune Biomarker Study for Salivary Gland Carcinoma | — | rekrutiert |
| Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy | — | rekrutiert |
| Immunophenotyping From Blood of Patients Suffering From Chronic Degenerating Joint Diseases and | — | rekrutiert |
| Improved Management of Patients With Recent-Onset Stable Chest Pain | ohne Phasenangabe | rekrutiert |
| Improvement of Understanding of Pediatric Sacral Neuromodulation: Therapeutic Strategies and Out | ohne Phasenangabe | rekrutiert |
| Influence of Presurgical Orthodontic Molding on the Growth of Newborns With Unilateral Cleft Lip | ohne Phasenangabe | rekrutiert |
| Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phen | Phase III | rekrutiert |
| International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lym | Phase III | rekrutiert |
| International HIT-MED Registry (I-HIT-MED) | — | rekrutiert |
| Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dy | Phase II | rekrutiert |
| Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated W | Phase III | rekrutiert |
| Investigation of the Clinical Efficacy of Low-dose Ionizing Radiation in the Treatment of Osteoa | ohne Phasenangabe | rekrutiert |
| Isatuximab in Adult Patients With Cytologic or Molecular Relapsed/Refractory CD38 Positive T-cel | Phase II | rekrutiert |
| LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated | Phase I / Phase II | rekrutiert |
| LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MAS | Phase III | rekrutiert |
| LUPUS-BEST - Treat-to-target in Systemic Lupus Erythematosus | ohne Phasenangabe | rekrutiert |
| LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Acti | Phase II | rekrutiert |
| Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Pha | Phase III | rekrutiert |
| Lonely in Depression | — | rekrutiert |
| Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies | ohne Phasenangabe | rekrutiert |
| Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRA | Phase III | rekrutiert |
| Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN | Phase III | rekrutiert |
| Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Curr | Phase III | rekrutiert |
| MB-CART19.1 in Refractory SLE | Phase I / Phase II | rekrutiert |
| MPN Childhood Registry | — | rekrutiert |
| MSOT and MRI for Non-invasive Assessment of Intestinal Transit Time in Children With Chronic Bow | ohne Phasenangabe | rekrutiert |
| MiCLASP Post Market Clinical Follow-Up (PMCF) Study | — | rekrutiert |
| More Than Just X-Rays - Imaging of Chemotherapy-induced Morphological and Functional Cardiovascu | ohne Phasenangabe | rekrutiert |
| Multispectral Optoacoustic Tomography for Advanced Imaging of Centronuclear Myopathy | — | rekrutiert |
| NIS to Examine Disease Activity in SLE Patients Treated With Subcutaneous Anifrolumab in Routine | — | rekrutiert |
| Neoadjuvant Darovasertib in Primary Uveal Melanoma | Phase III | rekrutiert |
| Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Ear | Phase II | rekrutiert |
| Neurovascular Product Surveillance Registry | — | rekrutiert |
| Nivolumab in Children and Adults With Nasopharyngeal Carcinoma | Phase II | rekrutiert |
| Non-invasive Evaluation of Graft Condition in Adult Patients With Kidney Transplant Using Ultras | — | rekrutiert |
| Non-invasive Preoperative Tissue Evaluation in Head and Neck Tumor Patients Using Multispectral | — | rekrutiert |
| OCTA in Cardiovascular Disease and Healthy Controls | ohne Phasenangabe | rekrutiert |
| Organ-preservative Therapy of Bladder Cancer With Radiotherapy or Radiochemotherapy Combined Wit | ohne Phasenangabe | rekrutiert |
| PROCARE - PROstate Cancer Real World Evidence Registry | — | rekrutiert |
| PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS | — | rekrutiert |
| Patient Relevant Outcomes Improvement Program in High Risk Hormone Receptor Positive (HR+) Breas | — | rekrutiert |
| Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Brea | Phase I / Phase II | rekrutiert |
| Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial) | Phase I | rekrutiert |
| Phase IIIb Study of Ribociclib + ET in Early Breast Cancer | Phase III | rekrutiert |
| Phenotypes, Biomarkers and Pathophysiology in Hereditary Spastic Paraplegias and Related Disorde | — | rekrutiert |
| Polycystic Ovarian Syndrome (PCOS) Biomarker Evaluation Study | — | rekrutiert |
| Post-Market Clinical Follow Up Study With Navitor Valve | — | rekrutiert |
| Post-Marketing Surveillance of Vliwazell® Prowound Dressing | — | rekrutiert |
| Praegnant Breast Cancer: Early/Advanced/Metastatic | — | rekrutiert |
| Prediction of Malignant Transformation of Oral Leukoplakia Using a MAGE-A-based Immunoscore | — | rekrutiert |
| Pridopidine Phase 3 Study in Huntington's Disease | Phase III | rekrutiert |
| Prospective Evaluation of Univentricular Hearts | ohne Phasenangabe | rekrutiert |
| Prospective Registry Study on the Implementation of Simultaneous Postoperative Radiochemotherapy | — | rekrutiert |
| Quantification of Brain and Kidney Perfusion Before, During, and After Hypothermia Treatment in | — | rekrutiert |
| Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia | ohne Phasenangabe | rekrutiert |
| Randomization of Single vs Multiple Arterial Grafts | ohne Phasenangabe | rekrutiert |
| Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blin | Phase II | rekrutiert |
| Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD- | Phase III | rekrutiert |
| Real World Data Collection on the INSPIRIS RESILIA Aortic Valve | — | rekrutiert |
| Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Cou | Phase IV | rekrutiert |
| Real-world Effectiveness Study of Long-term Treatment With Dupilumab in Participants ≥6 Years Wi | — | rekrutiert |
| Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis | — | rekrutiert |
| Real-world Experience With Lutetium Vipivotide Tetraxetan in Metastatic Castration Resistant Pro | — | rekrutiert |
| Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodul | — | rekrutiert |
| Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2 | Phase III | rekrutiert |
| Register Schweres Asthma - German Asthma Net e.V. | — | rekrutiert |
| Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib | Phase III | rekrutiert |
| SPYRAL GEMINI Pilot Study | ohne Phasenangabe | rekrutiert |
| SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresect | Phase III | rekrutiert |
| Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR | Phase III | rekrutiert |
| Safe and Timely Antithrombotic Removal (STAR) Registry | — | rekrutiert |
| Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Inve | Phase II / Phase III | rekrutiert |
| Salvage Brachytherapy and Hyperthermia for Recurrent H&N-tumours | ohne Phasenangabe | rekrutiert |
| Saruparib (AZD5305) Plus Camizestrant or Plus Endocrine Therapy, Compared With CDK4/6 Inhibitor | Phase III | rekrutiert |
| Single-Fraction Very Accelerated Partial Breast Irradiation (sfVAPBI) | ohne Phasenangabe | rekrutiert |
| Smart and Fit for Kidney Transplantation | ohne Phasenangabe | rekrutiert |
| Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy | — | rekrutiert |
| Streamlined Denervation With spYral For an Optimized Treatment (SPYRAL SWYFT) in Subjects With U | ohne Phasenangabe | rekrutiert |
| Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Bre | Phase I / Phase II | rekrutiert |
| Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or | Phase I / Phase II | rekrutiert |
| Study of Cabozantinib in Participants With Neuroendocrine Tumors Who Have Already Received Prior | — | rekrutiert |
| Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy. | Phase III | rekrutiert |
| Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in | Phase III | rekrutiert |
| Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Croh | Phase II | rekrutiert |
| Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Rea | — | rekrutiert |
| Study to Assess Real Life Effectiveness of Foslevodopa/Foscarbidopa in Adult German Participants | — | rekrutiert |
| Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid L | Phase I / Phase II | rekrutiert |
| Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Gr | Phase III | rekrutiert |
| THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for t | ohne Phasenangabe | rekrutiert |
| Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-A | Phase III | rekrutiert |
| The "Global Paradise System" Registry | — | rekrutiert |
| The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in I | Phase III | rekrutiert |
| The DefiPace Study | — | rekrutiert |
| The FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Reg | — | rekrutiert |
| The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associate | ohne Phasenangabe | rekrutiert |
| The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracol | — | rekrutiert |
| The Oxford Risk Factors And Non-Invasive Imaging Study | — | rekrutiert |
| Therapy Optimisation for the Treatment of Hairy Cell Leukemia | Phase II / Phase III | rekrutiert |
| Treatment Guided by Comprehensive Genome and Transcriptome Analysis Versus Standard of Care in A | — | rekrutiert |
| Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM AL | Phase III | rekrutiert |
| Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephali | Phase II | rekrutiert |
| Ultra-high-caloric, Fatty Diet in ALS | ohne Phasenangabe | rekrutiert |
| Ultrasound Localization Microscopy in Patient With Congenital Anomalies of the Kidney and Urinar | — | rekrutiert |
| Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed | Phase II | rekrutiert |
| Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocri | Phase II / Phase III | rekrutiert |